- Letter: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetes Patients (Diabetes Metab J 2011;35:41-9)
-
Lee MS, Kim HJ
- KMID: 2281718
- Diabetes Metab J.
- 2011 Apr;35(2):188-189.
- doi: 10.4093/dmj.2011.35.2.188
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Candidate Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes
-
Jang YM, Kim DL
- KMID: 2281709
- Diabetes Metab J.
- 2011 Apr;35(2):117-118.
- doi: 10.4093/dmj.2011.35.2.117
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Importance of Global Studies of the Genetics of Type 2 Diabetes
-
McCarthy M
- KMID: 2281706
- Diabetes Metab J.
- 2011 Apr;35(2):91-100.
- doi: 10.4093/dmj.2011.35.2.91
Genome wide association analyses have revealed large numbers of common variants influencing predisposition to type 2 diabetes and related phenotypes. These studies have predominantly featured European populations, but are now... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prediabetic Period: Review of Clinical Aspects
-
Rhee SY, Woo JT
- KMID: 2281708
- Diabetes Metab J.
- 2011 Apr;35(2):107-116.
- doi: 10.4093/dmj.2011.35.2.107
Hyperglycemia that does not satisfy the diagnostic criteria for diabetes mellitus (DM) is generally called prediabetes (preDM). The global prevalence of preDM has been increasing progressively in the past few... -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
-
Kim ST, Kim BJ, Lim DM, Song IG, Jung JH, Lee KW, Park KY, Cho YZ, Lee DH, Koh GP
- KMID: 2281719
- Diabetes Metab J.
- 2011 Apr;35(2):190-191.
- doi: 10.4093/dmj.2011.35.2.190
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
-
Barter PJ
- KMID: 2281707
- Diabetes Metab J.
- 2011 Apr;35(2):101-106.
- doi: 10.4093/dmj.2011.35.2.101
Type 2 diabetes is commonly accompanied by a low level of high density lipoprotein cholesterol (HDL-C) that contributes to the increased cardiovascular risk associated with this condition. Given that HDLs... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Stress in Korean Patients with Diabetes Mellitus Using the Problem Areas in Diabetes-Korea Questionnaire
-
Eom YS, Park HS, Kim SH, Yang SM, Nam MS, Lee HW, Lee KY, Lee S, Kim YS, Park IB
- KMID: 2281717
- Diabetes Metab J.
- 2011 Apr;35(2):182-187.
- doi: 10.4093/dmj.2011.35.2.182
BACKGROUND: It is known that diabetes and stress are directly or indirectly related, and that it is important to evaluate stress in patients with diabetes. The relationship between Korean diabetics... -
- CITED
-
- Close
- SHARE
-
- Close
- A Survey of Diabetic Educators and Patients for the Revision of Korean Food Exchange Lists
-
Cho JW, Kweon MR, Park YM, Woo MH, Yoo HS, Lim JH, Koo BK, Kim CH, Kim HJ, Park TS, Shin CH, Won KC, Lim S, Jang HC
- KMID: 2281716
- Diabetes Metab J.
- 2011 Apr;35(2):173-181.
- doi: 10.4093/dmj.2011.35.2.173
BACKGROUND: Food exchange lists are one of the main methods of nutritional education. However, Korean food exchange lists have not been revised since 1994. Therefore, we surveyed the opinions of... -
- CITED
-
- Close
- SHARE
-
- Close
- Adenoviruses Expressing PDX-1, BETA2/NeuroD and MafA Induces the Transdifferentiation of Porcine Neonatal Pancreas Cell Clusters and Adult Pig Pancreatic Cells into Beta-Cells
-
You YH, Ham DS, Park HS, Rhee M, Kim JW, Yoon KH
- KMID: 2281710
- Diabetes Metab J.
- 2011 Apr;35(2):119-129.
- doi: 10.4093/dmj.2011.35.2.119
BACKGROUND: A limitation in the number of insulin-producing pancreatic beta-cells is a special feature of diabetes. The identification of alternative sources for the induction of insulin-producing surrogate beta-cells is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
-
Lee JG, Kang DG, Yu JR, Kim YR, Kim JS, Koh GP, Lee DH
- KMID: 2281713
- Diabetes Metab J.
- 2011 Apr;35(2):149-158.
- doi: 10.4093/dmj.2011.35.2.149
BACKGROUND: Dipeptidyl peptidase 4 (DPP-4, also known as CD26) binds with adenosine deaminase (ADA) to activate T lymphocytes. Here, we investigated whether ADA activity is specifically affected by treatment with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Association of Unintentional Changes in Weight, Body Composition, and Homeostasis Model Assessment Index with Glycemic Progression in Non-Diabetic Healthy Subjects
-
Rhee EJ, Choi JH, Yoo SH, Bae JC, Kim WJ, Choi ES, Park SE, Park CY, Park SW, Oh KW, Park SW, Kim SW, Lee WY
- KMID: 2281712
- Diabetes Metab J.
- 2011 Apr;35(2):138-148.
- doi: 10.4093/dmj.2011.35.2.138
BACKGROUND: We performed a retrospective longitudinal study on the effects of changes in weight, body composition, and homeostasis model assessment (HOMA) indices on glycemic progression in subjects without diabetes during... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
-
Kim SA, Shim WH, Lee EH, Lee YM, Beom SH, Kim ES, Yoo JS, Nam JS, Cho MH, Park JS, Ahn CW, Kim KR
- KMID: 2281714
- Diabetes Metab J.
- 2011 Apr;35(2):159-165.
- doi: 10.4093/dmj.2011.35.2.159
BACKGROUND: Sitagliptin is a highly selective dipeptidyl peptide-4 (DPP-4) inhibitor that increases blood levels of active glucagon-like peptide (GLP)-1 and glucose-dependent insulinotrophic polypeptide (GIP), resulting in increased insulin secretion. While... -
- CITED
-
- Close
- SHARE
-
- Close
- Increasing Trend in the Number of Severe Hypoglycemia Patients in Korea
-
Kim JT, Oh TJ, Lee YA, Bae JH, Kim HJ, Jung HS, Cho YM, Park KS, Lim S, Jang HC, Lee HK
- KMID: 2281715
- Diabetes Metab J.
- 2011 Apr;35(2):166-172.
- doi: 10.4093/dmj.2011.35.2.166
BACKGROUND: To investigate whether the number of subjects with severe hypoglycemia who are brought to a hospital emergency department is increasing and to identify whether there have been changes in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
-
Lee MY, Shim MS, Kim BH, Hong SW, Choi R, Lee EY, Nam SM, Kim GW, Shin JY, Shin YG, Chung CH
- KMID: 2281711
- Diabetes Metab J.
- 2011 Apr;35(2):130-137.
- doi: 10.4093/dmj.2011.35.2.130
BACKGROUND: While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic... -
- CITED
-
- Close
- SHARE
-
- Close
